Human platelet lysate as a substitute for serum in natural killer cell generation and expansion

Chao Li; Hao Zhu; Lei Zhang; Xianwei Liu; Yibing Ji; Haihong Zhang; Zhongpeng Li; Chen Wu; Fangfang Zhu

doi:10.1093/lifemedi/lnad011

PDF(2136 KB)

Life Medicine ›› 2023, Vol. 2 ›› Issue (2) : 10. DOI: 10.1093/lifemedi/lnad011

Letter

Human platelet lysate as a substitute for serum in natural killer cell generation and expansion

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Chao Li, Hao Zhu, Lei Zhang, Xianwei Liu, Yibing Ji, Haihong Zhang, Zhongpeng Li, Chen Wu, Fangfang Zhu. Human platelet lysate as a substitute for serum in natural killer cell generation and expansion. Life Medicine, 2023, 2(2): 10 https://doi.org/10.1093/lifemedi/lnad011

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Wu SY, Fu T, Jiang YZ, et al. Natural killer cells in cancer biology and therapy. Mol Cancer 2020;19:120. CrossRef Google scholar

[2]	Saetersmoen ML, Hammer Q, Valamehr B, et al. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Semin Immunopathol 2019;41:59–68. CrossRef Google scholar

[3]	Dolstra H, Roeven MWH, Spanholtz J, et al. Successful transfer of umbilical cord blood CD34(+) hematopoietic stem and progenitor-derived NK cells in older acute myeloid leukemia patients. Clin Cancer Res 2017;23:4107–18. CrossRef Google scholar

[4]	Ni Z, Knorr DA, Kaufman DS. Hematopoietic and nature killer cell development from human pluripotent stem cells. Embryonic Stem Cell Immunobiology: Methods and Protocols 2013:33–41. CrossRef Google scholar

[5]	Li Y, Hermanson DL, Moriarity BS, et al. Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity. Cell Stem Cell 2018;23:181–192.e5. CrossRef Google scholar

[6]	Zhu H, Kaufman DS. An Improved Method to Produce Clinicalscale Natural Killer Cells from Human Pluripotent Stem Cells/In Vitro Differentiation of T-Cells. New York, NY: Humana, 2019, 107–119. CrossRef Google scholar

[7]	Bieback K, Hecker A, Kocaomer A, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009;27:2331–41. CrossRef Google scholar

[8]	Trebeden-Negre H, Vieillard V, Rosenzwajg M, et al. Polyvalent immunoglobulins, platelet lysate and lenalidomide: cocktail for polyfunctional NK cells expansion for multiple myeloma. Bone Marrow Transplant 2017;52:480–3. CrossRef Google scholar

[9]	Johnson CDL, Zale NE, Frary ED, et al. Feeder-cell-free and serumfree expansion of natural killer cells using cloudz microspheres, G-Rex6M, and human platelet lysate. Front Immunol 2022;13:803380. CrossRef Google scholar

[10]	Canestrari E, Charlebois S, Harris S. Human platelet lysate as a media supplement for ex vivo expansion of immune cells. Cytotherapy 2018;20:S61. CrossRef Google scholar